Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Creighton University
With
Novartis Pharmaceuticals
Must be allergic-asthma with IgE between 30 and 700 IU/ml.
Age
16–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
2 year history of ragweed allergic rhinitis
positive skin prick tests to ragweed \>5 mm wheal diameter
serum IgE \<700 iU/m
You may not be if
Use of prohibited medications (e.g. antihistamine in past 7 days and topical or oral corticosteroids in past 1 month, beta-agonist or theophylline for 1 week
History of immunotherapy in the past 2 years
Exposure to Omalizumab in the past 2 years
Clinically significant non-allergic or perennial rhinitis to avoid mediator release due to environmental allergens
Asthma other than mild intermittent
Women of childbearing potential who are not on an accepted form of birth control, as well as women who are breastfeeding
Known sensitivity to study drug Xolair
Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study
Patients with a previous history of cancer
Use of any other investigational agent in the last 30 days
